Archives DelveInsight

Cervical Cancer Market Has A Lot Going On Under The Hood

Sep 18, 2020

Cervical cancer is the fourth most common type of cancer and the fourth leading cause of death in women. The year 2018 reported approximately 570 000 cases of cervical ca...

Preventing Cervical Cancer Through Screening And HPV Vaccines

Sep 14, 2020

Cervical cancer is the fourth most commonly diagnosed cancer in women after breast cancer, colorectal cancer, and lung cancer. Although Cervical cancer rates vary geograp...

What Does The Acromegaly Pipeline Have Up In Its Sleeve?

Sep 11, 2020

In the span of a decade, the Acromegaly pipeline therapies, including IONIS-GHR-LRx (Ionis Pharmaceuticals), ATL1103 (Antisense Therapeutics), CAM2029 (Camurus), Veldoreoti...

Cycle Pharmaceuticals’ USD 25M Debt Financing; Bayer’s Phase IV REPLACE Trial; Verona’s Pilot Study with pMDI Ensifentrine in COVID Patients

Sep 8, 2020

Cycle Pharmaceuticals Hauls In USD 25 Million In A Debt Financing Agreement Cycle Pharmaceuticals, a biotech company focusing exclusively on rare diseases, announced ...

Multiple Myeloma: An Incurable B-cell malignancy and A Vicious Cycle of Relapse

Sep 7, 2020

The Multiple Myeloma Market is expected to grow during the study period 2017-30 due to a rich and robust pipeline, increasing incidence, and higher demand for novel therapi...

Keratoconus – Rare? Not really!

Sep 4, 2020

The Keratoconus market will be dominated by lenses, cross-linking procedures as well as IVMED-80, if approved in the coming decade. Keratoconus, away from the general perce...

Do We Have A Cure For Rosacea?

Aug 31, 2020

The current Rosacea Pipeline therapies include FMX103 (Foamix Pharmaceuticals), Epsolay (Sol-Gel Technologies), ACU-D1 (Accuitis), HY01 (Hovione Scientia Limited), AFX403...

The Rarity Of Dravet Syndrome: Challenges, and Treatments

Aug 28, 2020

As per DelveInsight, the Dravet syndrome market size was estimated to be USD 79.1 Million in 2017, which is expected to increase at a significant CAGR during the study peri...

What Can Help Manage The Insufficient Pancreas?

Aug 24, 2020

The launch of the Pipeline therapies, increasing EPI prevalence shall fuel the Exocrine pancreatic insufficiency market size estimated to be approximately USD 1,695.26 Mill...

Interstitial Cystitis: A big opportunities for emerging drugs

Aug 21, 2020

Interstitial Cystitis market comprises robust pipeline therapies in late and mid-stage development, which are expected to be launched shortly, such as KRP-116D (Kyorin Phar...

Sanofi acquires Principia; FDA’s Nod to Roche’s Enspryng; BMS, Dragonfly’s Licensing Deal

Aug 18, 2020

New strategy, new outlook: Sanofi takes another step, gains full control over the Principia’s MS treatment Sanofi has inked a definitive agreement with Principia Biopha...

New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves

Aug 17, 2020

The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019 and is anticipated to increase at a CAGR for the study period 2017-2030 owing to dynam...

Celiac Disease: The Hidden Epidemic of Gluten Sensitivity

Aug 20, 2020

The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is ...

How GSK, Chiesi Farmaceutici, Regeneron/Sanofi, Novartis, and AB Science are trying to benefit patients afflicted with Inadequately Controlled Asthma?

Aug 13, 2020

ATS 2020 Virtual is happening from August 5 to August 10, and it is exciting to watch major Respiratory Pharmaceutical companies and their key presentations. GlaxoSmithKlin...

Infectious Diseases That Possess Significant Challenge To Humans Health

Aug 12, 2020

Infectious diseases or communicable diseases are one of the leading causes of death worldwide. These diseases are spread by pathogenic microorganisms, such as bacteria, vir...